Financials
- Market Capitalization 51.75 M
- Employee 8
- Founded 2018
- CEO N/A
- Website www.impactbiomedinc.com
- Headquarter Nevada, United States
- FIGI BBG01JFZG014
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
0.52
Relación precio/flujo de caja
513.45
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4112 | VBIO Valion Bio, Inc. - Common stock | 3.12 USD | +1.63% | +1980.00% | +875.00% | +160.00% | 69.23 M USD | ||
| 4160 | EXOZ eXoZymes Inc. - Common Stock | 6.79 USD | +4.46% | +2.26% | +39.71% | -30.00% | 63.02 M USD | ||
| 4288 | SCLX Scilex Holding Company - Common Stock | 5.35 USD | -0.93% | -5.31% | -19.18% | -34.19% | 45.44 M USD | ||
| 4373 | MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.85 USD | -1.16% | +13.33% | +30.77% | -39.29% | 35.72 M USD |